Cargando…
The cost and value of cancer drugs – are new innovations outpacing our ability to pay?
Cancer drug expenditures have been increasing significantly in countries around the world. A recent paper in the IJHPR provides new knowledge and insights into this global phenomenon by analyzing how it is playing out in an Israeli health plan with over two million members, whose state-of-the-art in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032240/ https://www.ncbi.nlm.nih.gov/pubmed/27688873 http://dx.doi.org/10.1186/s13584-016-0097-0 |